Cellebrite DI Ltd. (CLBT): who owns it and who trades it
As of Nov 16, 2026, CLBT insiders reported 17 open-market sales worth $5.4M and no purchases in the last 12 months, with 2% of the sale value made under pre-set 10b5-1 plans. The largest seller was Thomas E. Hogan (CEO), with $4.1M. 5 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Cellebrite DI
From the latest filingsOverall: more selling than buying. Insiders mostly sold. Famous investors mostly bought. Funds was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns CLBT
200 funds and institutions reported CLBT shares worth $1.8B at the end of Q2 2026, about 50% of the company. The largest holder is True Wind Capital Management, L.P. with 5.6%.
Funds and institutions (13F) 50%Everyone else 50%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| True Wind Capital Management, L.P. | 13.86M | 5.56% | $202M | No change |
| Voss Capital, LP | 11.44M | 4.59% | $167M | +18% |
| Pertento Partners LLP | 8.00M | 3.21% | $117M | +20% |
| Phoenix Financial Ltd. | 6.18M | 2.48% | $90.2M | +48% |
| FMR LLC (Fidelity) | 5.97M | 2.39% | $87.2M | -30% |
| BlackRock, Inc. | 5.68M | 2.28% | $83M | +70% |
| Nine Ten Capital Management LLC | 4.13M | 1.65% | $60.3M | +20% |
| Artisan Partners Limited Partnership | 3.27M | 1.31% | $47.7M | +49% |
| Wellington Management Group LLP | 3.05M | 1.22% | $44.5M | +94% |
| Clal Insurance Enterprises Holdings Ltd | 2.77M | 1.11% | $40.5M | -13% |
| T. Rowe Price Investment Management, Inc. | 2.38M | 0.95% | $34.8M | -28% |
| Morgan Stanley | 2.19M | 0.88% | $32M | +5% |
| Renaissance Technologies LLC | 2.15M | 0.86% | $31.4M | -25% |
| Capital World Investors | 2.11M | 0.85% | $30.8M | +880% |
| Capital International Investors | 2.06M | 0.83% | $30.1M | -10% |
| Progeny 3, Inc. | 2.00M | 0.80% | $29.2M | +77% |
| Portolan Capital Management, LLC | 1.93M | 0.77% | $28.2M | -11% |
| Weiss Asset Management LP | 1.92M | 0.77% | $28.1M | +1% |
| Ashford Capital Management Inc | 1.78M | 0.71% | $26M | +1% |
| Bank of New York Mellon Corp | 1.74M | 0.70% | $25.5M | +31% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, CLBT insiders reported $0 of open-market purchases and $5.4M of sales. 2% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 12, 2026 | David Nicholas Gee | Chief Marketing Officer | Sale | 234 | $13.31 | $3.1K | Form 4 |
| Nov 12, 2026 | Marcus Jewell | Global Chief Revenue Off | Sale | 393 | $13.31 | $5.2K | Form 4 |
| Oct 16, 2026 | David Barter | CFO | Sale | 12,134 | $11.21 | $136K | Form 4 |
| Aug 25, 2026 | Thomas E. Hogan | Other | Sale | 25,299 | $11.29 | $286K | Form 4 |
| Aug 24, 2026 | David Nicholas Gee | Chief Marketing Officer | Sale plan | 4,323 | $11.36 | $49.1K | Form 4 |
| Aug 21, 2026 | Marcus Jewell | Global Chief Revenue Off | Sale | 12,562 | $11.24 | $141K | Form 4 |
| Aug 21, 2026 | David Nicholas Gee | Chief Marketing Officer | Sale | 2,198 | $11.24 | $24.7K | Form 4 |
| Aug 12, 2026 | Thomas E. Hogan | CEO | Sale | 139,713 | $15.39 | $2.2M | Form 4 |
| Aug 12, 2026 | Marcus Jewell | Global Chief Revenue Off | Sale | 411 | $16.07 | $6.6K | Form 4 |
| Aug 12, 2026 | David Nicholas Gee | Chief Marketing Officer | Sale | 230 | $16.07 | $3.7K | Form 4 |
| Jul 8, 2026 | David Barter | CFO | Sale | 41,734 | $16.38 | $684K | Form 4 |
| Jul 2, 2026 | Thomas E. Hogan | CEO | Sale | 103,188 | $15.76 | $1.6M | Form 4 |
| May 21, 2026 | David Nicholas Gee | Chief Marketing Officer | Sale plan | 2,243 | $13.10 | $29.4K | Form 4 |
| May 21, 2026 | David Nicholas Gee | Chief Marketing Officer | Sale plan | 3,430 | $13.15 | $45.1K | Form 4 |
| May 18, 2026 | Marcus Jewell | Global Chief Revenue Off | Sale | 12,658 | $12.77 | $162K | Form 4 |
| May 12, 2026 | David Nicholas Gee | Chief Marketing Officer | Sale | 228 | $13.01 | $3K | Form 4 |
| May 12, 2026 | Marcus Jewell | Global Chief Revenue Off | Sale | 383 | $13.01 | $5K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Thomas E. Hogan | Chief Executive Officer, Director | – | $4.1M | Aug 25, 2026 |
| David Barter | Chief Financial Officer | – | $820K | Oct 16, 2026 |
| Marcus Jewell | Global Chief Revenue Officer | – | $320K | Nov 12, 2026 |
| David Nicholas Gee | Chief Marketing Officer | – | $158K | Nov 12, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
CLBT short interest
5.64M CLBT shares are sold short. Over the last 12 reports the number of shares short went up 21%.
As of Oct 30, 2026, 5.64M CLBT shares were sold short, down 21.9% from the report before. At the average daily volume of 1.30M shares, buying them all back would take about 4.3 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 5.64M | – | -22% | 1.30M | 4.3 |
| Oct 15, 2026 | 7.22M | – | -11% | 1.88M | 3.8 |
| Sep 30, 2026 | 8.08M | – | -15% | 2.79M | 2.9 |
| Sep 15, 2026 | 9.47M | – | +14% | 2.72M | 3.5 |
| Aug 31, 2026 | 8.29M | 3.33% | +8% | 3.88M | 2.1 |
| Aug 14, 2026 | 7.68M | 3.08% | -6% | 5.34M | 1.4 |
| Jul 31, 2026 | 8.15M | 3.27% | +16% | 1.13M | 7.2 |
| Jul 15, 2026 | 7.01M | 2.81% | +1% | 1.98M | 3.5 |
| Jun 30, 2026 | 6.95M | 2.79% | +26% | 2.23M | 3.1 |
| Jun 15, 2026 | 5.50M | 2.21% | +33% | 1.97M | 2.8 |
| May 29, 2026 | 4.14M | 1.66% | -11% | 2.40M | 1.7 |
| May 15, 2026 | 4.65M | 1.87% | +11% | 2.65M | 1.8 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Cellebrite DI financials
Famous investors that hold CLBT
5 of the 50 well-known investors we track reported holding CLBT in their latest 13F filing. The largest position is Jim Simons's, worth $21.6M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Jim Simons · Renaissance Technologies | Q3 2026 | 1.92M | $21.6M | 0.0% | -11% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 801,165 | $9M | 0.0% | +55% |
| Steve Cohen · Point72 Asset Management | Q3 2026 | 286,323 | $3.2M | 0.0% | +900% |
| Israel Englander · Millennium Management | Q3 2026 | 217,872 | $2.5M | 0.0% | New |
| Cathie Wood · ARK Investment Management | Q3 2026 | 139,021 | $1.6M | 0.0% | -19% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named CLBT in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Oct 9, 2026 | Pertento Partners LLP | 13G | 5.2% |
| Oct 9, 2026 | Pertento Partners LLP | 13G | 5.2% |
Questions about Cellebrite DI Ltd. (CLBT) stock
Who owns the most CLBT stock?
The largest reported owner of Cellebrite DI Ltd. (CLBT) is True Wind Capital Management, L.P., with 5.6% of the company. In total, 200 funds and institutions reported holding CLBT at the end of Q2 2026, together about 50% of the shares. See the largest owners.
Are CLBT insiders buying or selling?
In the last 12 months, CLBT insiders reported no open-market purchases and 17 sales worth $5.4M. The latest trade was on Nov 12, 2026. See every trade.
What is the short interest in CLBT?
As of Oct 30, 2026, 5.64M CLBT shares were sold short, down 21.9% from the report before. At the average daily volume of 1.30M shares, buying them all back would take about 4.3 trading days (days to cover). See the history.
Which famous investors hold CLBT?
5 of the 50 well-known investors we track reported CLBT in their latest 13F filing, including Jim Simons, Ken Griffin, Steve Cohen. The largest position is worth $21.6M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.